The European Medicines Agency (EMA) has accepted Almirall’s application to [...]

bionyra-pharma-series-a-immunology Bionyra Pharma has launched with a $165 million Series [...]

Hyphens Pharma International Limited (Hyphens Pharma), a Singapore-based specialty pharmaceutical [...]

Almirall has hosted the fourth edition of ImmunoSkin, its annual [...]

Almirall, a global biopharmaceutical company focused on medical dermatology, has [...]

KBI Biopharma has entered a collaboration with Infinimmune to support [...]

Revolo Biotherapeutics says it is accelerating plans to bring a [...]

Nektar Therapeutics has received FDA Fast Track designation for its [...]

New analysis reveals billions risked on overly complex trials that [...]